Publicaciones en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (16)

2023

  1. Women with psychotic episodes during pregnancy show increased markers of placental damage with Tenney-Parker changes

    Histology and Histopathology, Vol. 38, Núm. 10, pp. 1109-1118

2021

  1. Erratum: Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19 (Journal of Perinatal Medicine (2020) 48:9 (950-958) DOI: 10.1515/jpm-2020-0355)

    Journal of Perinatal Medicine

  2. Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection

    Ultrasound in Obstetrics and Gynecology, Vol. 57, Núm. 2, pp. 232-241

  3. SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave

    BMC Pregnancy and Childbirth, Vol. 21, Núm. 1

2020

  1. Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): A secondary analysis of the WAPM study on COVID-19

    Journal of Perinatal Medicine, Vol. 48, Núm. 9, pp. 950-958

2008

  1. Long-term response to highly active antiretroviral therapy with lopinavir/ritonavir in pre-treated vertically HIV-infected children

    Journal of Antimicrobial Chemotherapy, Vol. 61, Núm. 1, pp. 183-190

2007

  1. Prevalencia de resistencia a fármacos antirretrovirales en España

    Anales de Pediatria, Vol. 67, Núm. 2, pp. 104-108

2006

  1. Effects of highly active antiretroviral therapy with nelfinavir in vertically HIV-1 infected children: 3 years of follow-up. Long-term response to nelfinavir in children

    BMC Infectious Diseases, Vol. 6

  2. Impact of long-term viral suppression in CD4+ recovery of HIV-children on Highly Active Antiretroviral Therapy

    BMC Infectious Diseases, Vol. 6

  3. La terapia combinada puede ser tan efectiva como la terapia antirretroviral de alta eficacia en el control de la carga viral en niños con un sistema inmunitario conservado

    Acta Pediatrica Espanola, Vol. 64, Núm. 8, pp. 377-382

  4. Long-term effects of highly active antiretroviral therapy in pretreated, vertically HIV type 1-infected children: 6 Years of follow-up

    Clinical Infectious Diseases, Vol. 42, Núm. 6, pp. 862-869

  5. Low immunologic response to highly active antiretroviral therapy in naive vertically human immunodeficiency virus type 1-infected children with severe immunodeficiency

    Pediatric Infectious Disease Journal, Vol. 25, Núm. 4, pp. 365-368

2004

  1. The effects on infants of potent antiretroviral therapy during pregnancy: A report from Spain

    Medical Science Monitor, Vol. 10, Núm. 5

2003

  1. Viral Load and CD4+ T Lymphocyte Response to Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Children: An Observational Study

    Clinical Infectious Diseases, Vol. 37, Núm. 9, pp. 1216-1225

2002

  1. Immunologic recovery after 2-years on HAART in vertically HIV-infected children

    Medicina Clinica, Vol. 118, Núm. 16, pp. 601-604

  2. Respuesta al tratamiento antirretroviral en niños infectados verticalmente por el virus de la inmunodeficiencia humana tipo 1

    Medicina Clinica, Vol. 119, Núm. 19, pp. 725-729